GeneDx stockholders elect Katherine Stueland as Class II director, ratify auditor, approve say-on-pay

GeneDx Holdings Corp.

Katherine Stueland elected Class II director: 18,325,894 for, 5,893,466 withheld, 3,409,327 broker non-votes.
Ernst & Young ratified as independent auditor for FY2026: 27,466,639 for, 158,884 against.
Advisory vote on executive compensation approved: 22,705,946 for, 1,471,593 against.
Future say-on-pay frequency set at every 1 year: 23,816,121 votes for 1 year (majority).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.